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A molecular and genetic view of human renal and urinary tract weeks of gestation, and the first layer of glomeruli forms
malformations. by nine weeks. Branching and nephrogenesis continue
Malformations of the kidney and lower urinary tract are to occur in the outer rim of the kidney, the nephrogeniccommon causes of chronic renal failure in infants and young
cortex, until 34 weeks, whereas further maturation, inchildren, but little is known about the molecular pathogenesis
the form of growth and differentiation, continues postna-of these disorders. In animal experiments, the main causes
of malformation are mutations, chemical and pharmaceutical tally. The ureteric bud also gives rise to the epithelium
teratogens, obstruction of fetal urinary flow, and alterations of of the renal pelvis, the ureter, and the bladder trigone,
maternal nutrition. The focus of this review is to consider
also called the urothelium. However, the main part of thehow mutations and other alterations of gene expression during
trigone is derived from the Wolffian (mesonephric) duct,development cause human urinary tract malformations. Some
of these disorders are associated with congenital anomalies in as it is absorbed into the posterior wall of the cloaca.
multiple organ systems, and two such syndromes are considered The remainder of the bladder epithelium is derived from
in detail: first, the renal-coloboma syndrome, in which muta- endoderm, and both ureter and bladder become enveloped
tions of the PAX2 transcription factor cause partial failure of
in mesodermal-derived smooth muscle. During the secondurinary tract growth; second, Kallmann’s syndrome, in which
half of human gestation, fetal urine is the main compo-mutations of a cell-signaling molecule are associated with the
absence of the urinary tract. In patients seen by nephrologists nent of amniotic fluid and is thought to be important for
and urologists, however, most urinary tract malformations oc- fetal lung growth. However, the production of urine be-
cur in isolation, and in some of these individuals, a genetic fore birth is not essential for fetal survival, since the pla-pathogenesis is strongly suggested by a positive family history
centa effectively performs hemodialysis and gas exchange.and genetic linkage studies. One common example is primary
vesicoureteric reflux. Furthermore, sporadic malformations
have been shown to be associated with polymorphisms of genes
THE SPECTRUM OF URINARYexpressed during construction of the urinary tract. In the long
term, an understanding of the genetic aspects of human urinary TRACT MALFORMATIONS
tract malformations will help to unravel the pathogenesis of
As might be expected for such a complex pattern ofthese disorders and may facilitate the design of genetic screen-
development, these processes are often perturbed [3, 4],ing tests with a view to early diagnosis.
making kidney and lower urinary tract malformations a
relatively common occurrence (for simplicity, hereafter
the term “urinary tract” refers to both kidney and lowerThe mammalian kidney derives from two tissue com-
urinary tract; Table 1). Furthermore, since the develop-partments of the embryonic metanephros: the ureteric
ment of the ureteric bud and renal mesenchyme dependsbud, an epithelium that branches recurrently to form
on mutually inductive interactions [5, 6], it is not surpris-the collecting ducts, and the renal mesenchyme, which
undergoes an epithelial transformation to form nephron ing that a primary defect of either component will affect
components, including glomerular and proximal tubule the development of its partner. This provides one expla-
epithelia [1, 2]. The human metanephros appears at five nation for the clinical observation that an abnormal in-
sertion of the ureter into the bladder is associated with
congenital renal parenchymal defects [7, 8]. In such cases,
Key words: embryonic metanephros, renal mesenchyme, congenital
the altered insertion may reflect a delayed or prematurerenal parenchymal defects, kidney malformation, primary vesicoure-
teric reflux. branching of the ureteric bud from the mesonephric duct.
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Table 1. The spectrum of urinary tract malformations human disease, and several excellent reviews that detail
the biology of the other areas, in which animal data areUpper urinary tract
Renal agenesis: kidney is absent predominant, have been discussed [9–11].
Renal dysplasia: kidney contains undifferentiated tissues and may Four potent reasons highlight why it is timely to focusbe a tiny (aplasia) or distended by cysts (multicystic and cystic
on the molecular and genetic bases of human urinarydysplastic kidneys)
Renal hypoplasia: kidney contains formed nephrons but significantly tract malformations.
fewer than normal; when nephrons are large the condition is called (1) With the increasing use of fetal ultrasound scan-oligomeganephronia
ning, more individuals with congenital urinary tract mal-Duplex kidney: the organ is separated into an upper part, which is
often dysplastic and attached to an obstructed ureter, and a lower formation are being diagnosed [12–15]. In fact, these
part attached to a refluxing ureter disorders account for about 30% of all prenatally diag-Horseshoe kidney: both kidneys have become fused during develop-
nosed anomalies [16]. Although many appear to havement and may include dysplastic components
minimal clinical significance, for the more serious anom-Lower urinary tract
Agenesis: the ureter and bladder trigone are absent alies, such as bilateral renal agenesis or dysplasia, early
Hydronephrosis: the renal pelvis is distended and the parenchyma diagnosis allows consideration of termination or active
may be hypoplastic or dysplastic—the ureter may be refluxing or
therapeutic intervention. The latter includes fetal de-obstructed
Duplication of the ureter: may occur in association with a duplex compression of obstructed urinary tracts, as well as plan-
kidney ning for the need for dialysis soon after birth [16]. In
Vesicoureteric reflux: urine flows retrograde from the bladder into
these severe cases, accompanying lung hypoplasia canthe ureter, pelvis and medullary collecting ducts of the kidney
Posterior urethral valves: the outflow to the urinary bladder is ana- also be life-threatening after birth.
tomically obstructed (2) Severe urinary tract malformations constitute the
The following incidences have been quoted [20]: duplex ureter, 1/20; vesicoure- main cause of chronic renal failure in young children
teric reflux, 1/50–100; horseshoe kidney, 1/200; unilateral renal agenesis, 1/500–
[17, 18]. For example, in our own clinical service at Great1000; unilateral multicystic kidney, 1/5000; bilateral agenesis/dysplasia, 1/5000–
10,000. Ormond Street Hospital for Children (London, UK),
malformations account for over 80% of children under
five years old with end-stage renal failure. With advances
in technology, babies with minimal renal function canbe a failure of nephron induction together with a partial
be dialyzed from birth, and toddlers can receive kidneyfailure of mesenchyme-driven ureteric bud differentiation.
transplants from the age of one year. These strategies,Human urinary tract malformations are phenotypi-
together with general improvements in the care of chil-cally diverse but have in common a failure of normal
dren with chronic renal failure, will ultimately mean andevelopment before birth (Table 1). For instance, in
increase in long-term survival into the adult period foragenesis, the kidney and ureter are absent, whereas dys-
these individuals.plastic kidneys contain undifferentiated tissues and are
(3) The description of familial cases of urinary tractoften attached to structurally abnormal lower urinary
malformations has made it feasible to perform not onlytracts. Other varieties are listed in Table 1. Any bilateral
genetic linkage studies, but also the search for specificrenal malformation can be associated with oligohydram-
gene mutations. Even in apparently sporadic cases, ge-nios, oligoanuria, and lung hypoplasia, and this is termed
netic analyses can be used (for example, association stud-the “Potter sequence.” The definition of malformation
ies), as described later in this article. In some cases, thecan be extended to microscopic abnormalities such as
urinary tract disorder occurs with a multiorgan malfor-“tubular dysgenesis,” where proximal tubules form ab-
mation syndrome commonly affecting central nervous,normally. The polycystic kidney diseases have been ex-
cardiovascular, and skeletal systems. For a listing of suchcluded from the current discussion because, although
syndromes, the reader is referred to other referencessome types can affect infants and children [3, 4], the
[19, 20] and to the constantly updated version of Onlinecysts arise from forming or formed nephrons after the
Mendelian Inheritance in Man (http://www4.ncbi.nlm.nih.early embryonic period of organogenesis.
gov/Omim/). Although malformation syndromes are in-
dividually rare, they collectively account for considerable
CAUSES OF URINARY morbidity. Some are associated with gross chromosomal
TRACT MALFORMATIONS anomalies such as monosomies, trisomies, 4p-syndrome
and dup(10p)/del(10q) [21–24], but cytogenetic aberra-Based in animal experiments, the major postulated
influences that perturb urinary tract development com- tions are absent in most cases of urinary tract malforma-
tion syndromes. Other renal malformation syndromesprise mutations, chemical and pharmacological terato-
gens, urinary tract obstruction, and maternal undernutri- are inherited in Mendelian patterns, and in several of
them, disease loci and mutations have been defined (Ta-tion (Fig. 1). The remit of this article is to focus on
how mutations and other secondary alterations of gene ble 2 in [20]).
(4) The explosion of knowledge regarding the mecha-activity alter the program of development to generate
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Fig. 1. Influences on gene expression during development of the urinary tract. These are mutations, chemical and pharmaceutical teratogens,
physical obstruction of urine flow in the fetus, and alterations in maternal diet.
nisms of murine urinary tract development is impacting either WTI or PAX2 transcription factor genes cause
on our understanding of human malformations [20]. In renal agenesis) [25, 26]; (2) the presence and severity of
1967, Grobstein was the first to demonstrate that mouse the urinary tract malformation are often dependent on
metanephric mesenchyme and ureteric bud failed to dif- the genetic background of the animal [27]; and (3) in
ferentiate when cultured separately, but they formed some instances, more than one related gene must be
nephrons and collecting ducts when recombined [5]. Us- mutated before development is perturbed [28, 29].
ing genetically engineered mice and organ culture, it In the remainder of this review, two malformation
is now established that nephrogenesis is controlled by syndromes are presented that act as striking examples
diverse molecules, some of which may act as inductive in which advances in genetics have illuminated the patho-
signals postulated by Grobstein. These molecules include genesis of abnormal urinary tract development. Second,
transcription factors, growth factors, and adhesion mole- the question of whether nonsyndromic human urinary
cules, which are essential for control of cell survival, tract anomalies may have a genetic basis is considered.
proliferation, differentiation, and morphogenesis during
normal mammalian development [6, 20]. Furthermore,
THE RENAL COLOBOMA SYNDROME ANDthe phenotypes of some mouse mutants are strikingly
THE PAX2 STORYsimilar to human disease, hence suggesting candidate
As renal mesenchymal cells begin to differentiate intogenes. Mutant mice also demonstrate the following: (1)
nephron tubules, they aggregate into condensates andthe same urinary tract malformation can result from mu-
tation of different genes (for example, null mutation of undergo a burst of proliferation with increased expres-
c
Fig. 2. PAX2 in normal and abnormal development of the urinary tract. (A) Low-power view of human fetal kidney at 11 weeks’ gestation with
PAX2 protein shown in blue. Note the high expression in nephrogenic cortex (c) with down-regulation in more mature structures, including
glomeruli (g) and the medulla (m). (B) High-power view of the nephrogenic cortex from A. Note the intense staining for the PAX2 transcription
factor protein in early nephron condensates (n), which flank the branch tip of a ureteric bud (u). (C) Scheme to show how the metanephros can
develop into a normal kidney and ureter, or into a hypoplastic kidney with malformed ureter, associated with too little PAX2 expression, or into
a tumor or muticystic dysplastic kidney in which epithelia overexpress PAX2 (blue).
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sion of PAX2 transcription factor (Fig. 2) [30, 31]. At model, the widespread deregulation of PAX2 expression
in neonatal kidneys is likely to drive epithelial over-the same time, the termini of the adjacent ureteric bud
branches express the same gene and are highly prolifera- growth, although an alternative explanation for cyst for-
mation would be a nonspecific effect of accompanyingtive. Later in nephrogenesis, both proliferation and PAX2
expression are down-regulated. Urinary tract growth is proteinuria, as occurs in some forms of human congenital
nephrotic syndrome. In addition, a recent publication byimpaired in mice with inactivating PAX2 mutations [26,
32, 33]. Null mutants lack kidneys and ureters because Ostrom et al clearly demonstrates that reduced PAX2
gene dosage slows cyst growth in the mouse cpk/cpkthe ureteric bud fails to branch from the mesonephric
(Wolffian) duct, while an associated absence of fallopian model of cystic kidney disease, most likely by altering
the ratio between apoptosis and proliferation [46].tubes in female embryos is explained by the expression
of PAX2 in Mullerian duct development. Haploinsuffi- In cases of nonsyndromic human renal dysplasia, there
is evidence of altered PAX2 expression. Although thereciency (a partial lack of functional protein) in heterozy-
gous PAX2 1/2 mice is associated with renal hypoplasia is no evidence that this is due to PAX2 mutations, this
secondary phenomenon may nevertheless contribute toand, in some cases, hydonephrosis and hydroureter, con-
sistent with the presence of vesicoureteric reflux. complex biology of these malformations. Microdissec-
tion studies by Potter revealed that most human dysplas-The human renal-coloboma syndrome [Mendelian In-
heritance in Man (MIM) number 120330] has a striking tic kidney tubules are malformed branching structures
that often terminate in cysts [3]. Human renal dysplasticphenotypic similarity to PAX2 1/2 mice. It is comprised
of various degrees of ocular impairment, including blind- epithelia harvested from terminations of pregnancy ex-
press PAX2 as well as BCL2, [31] a cell survival moleculeness, caused by an optic nerve malformation, the colo-
boma, with vesicoureteric reflux and hypoplastic kidneys. [47, 48], and galectin-3, a molecule implicated in epithe-
lial growth [31, 49]. Strikingly, dysplastic organs harvestedSanyanusin et al described heterozygous mutations of
PAX2 (chromosome 10q24-q25) in one kindred [34], and postnatally show persistent patterns of fetal epithelial gene
expression, whereas normal organs down-regulate prolif-reports of other affected individuals followed [35–37].
The eye disease is explained by PAX2 expression during eration, PAX2 (Fig. 2), and BCL2 in mature epithelia.
Cystic dysplastic epithelia have a high rate of prolifera-ocular development, and it is notable that PAX2 1/2
mutant mice also have eye disease [32, 33]. The first re- tion, as assessed by expression of proliferating cell nu-
clear antigen, hence explaining why some of these renalported human mutation was demonstrated to have arisen
de novo with subsequent inheritance in a dominant man- malformations grow to distend the abdomen of infants.
Furthermore, the proliferative state of dysplastic epithe-ner [34]. It most likely caused haploinsufficiency because
the mutated gene coded for a protein with an intact lia in vitro correlates with levels of PAX2 and BCL2
proteins (abstract; Yang et al, J Am Soc Nephrol 10:DNA-binding paired box, an interrupted octapepide do-
main and a novel, truncated, carboxyterminal, which was 445A, 1999). It is therefore notable that tumors occasion-
ally arise in multicystic kidneys [50–52], and these dys-postulated to perturb the transactivation of target genes.
Homozygous PAX2 mutations have yet to be described plastic organs may harbor nephrogenic blastema and
perilobular rests, the latter being considered a Wilms’in humans, although kindreds with kidney, oviduct, and
uterus malformations [38, 39] superficially resemble tumor precursor, which also express PAX2 [30]. Con-
versely, apoptosis is dominant in mesenchyme aroundmouse null-mutants [26]. Of interest, in humans, muta-
tions of other members of the PAX gene family cause dysplastic epithelia, a compartment that has low PAX2
and BCL2 expression [31, 53, 54].Waardenburg syndromes (PAX3) and aniridia (PAX6),
although these do not have renal components, reflecting Since multicystic dysplastic kidneys are usually associ-
ated with an “atretic” ureter, obstruction early in gesta-the organ-specific activities of the respective genes. The
search for mutations of PAX2 in human, nonsyndromic tion has been invoked as a cause of the malformation,
and in this context, it is interesting to note that renal cystvesicoureteric reflux is discussed later in this article.
Thus, in mice and humans, PAX2 deficiency causes formation associated with epithelial hyperproliferation
and PAX2 overexpression can be induced by 10 days ofimpairment of urinary tract growth, but what are the ef-
fects of PAX2 overexpression? As depicted in Figure 2, midgestation experimental ureteric obstruction in sheep
[55]. One explanation for this effect is that increasedPAX2 is expressed in human and experimental murine
Wilms’ tumors [30, 40, 41] and also in human renal carci- hydrostatic pressure caused by urinary flow impairment
may stretch the metanephric epithelia, hence triggeringnoma [42], where experimental ablation of PAX2 activity
by antisense oligonucleotides reduced cell proliferation PAX2 expression and hyperproliferation. In fact, it can
be demonstrated that increased pressure is associatedof renal carcinoma lines in vitro. Indeed, PAX2 trans-
forms murine cells and inhibits the promoter of p53, a with proliferation in vitro in cysts from Madin-Darby
canine kidney cells, a line derived from the ureteric bud/tumor suppressor [43, 44] and transgenic overexpression
of PAX2 generates renal cysts in mice [45]. In the latter collecting duct lineage [56].
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KALLMANN’S SYNDROME AND ment have “hyperfiltration damage,” a decline in func-
tion of too few glomeruli, which have hypertrophied andRENAL AGENESIS
sclerosed [69]. Although renal histology in Kallmann’sX-linked Kallmann’s syndrome (MIM 308700) is caused
syndrome is unknown, glomerulosclerosis can occur inby mutations of KAL-1 (also called KALIG1 and ADMLX),
other individuals with nonsyndromic congenital solitarya gene located on the short arm of the X chromosome
kidneys, a condition affecting 1 out of 1000 of the general(Xp22.3) [57, 58]. Anosmia and hypogonadotrophic hy-
population [70–72] and in oligomeganephronic renal hy-pogonadism occur in affected males because of defective
poplasia [73, 74]. Alternatively, renal damage might beprenatal elongation of axons of olfactory neurons and
caused by exposure to an abnormal lower urinary tractmigration of gonadotrophin-releasing hormone-synthe-
because a Kallmann’s syndrome patient reported bysizing neurons from the nasal placode into the forebrain.
Duke et al had focal renal scarring compatible with vesi-Moreover, the olfactory bulb fails to grow and is hypo-
coureteric reflux [68], and Wegenke et al reported anplastic [59]. Other, less constant features include mirror
X-linked case with a solitary but duplex renal tract [64].movements of the hands, pes cavus, high arched palate,
The upper renal moiety was attached to a dilated ureter,and cerebellar ataxia. The significance of this syndrome
while the lower part connected to a separate ureter withto this current discussion is that it constitutes a “human
vesicoureteric reflux.genetic model” of renal agenesis: This absent kidney
When KAL-1 is expressed in vitro, the expressed pro-is usually unilateral, resulting in a solitary functioning
tein, called anosmin-1, appears on the cell surface andkidney. Obligate female carriers of X-linked Kallmann’s
in the culture medium: Hence, KAL-1 may code for asyndrome are hyposmic but lack classic features of the
secreted signaling molecule [75]. The predicted proteinsyndrome [60].
has four fibronectin type III repeats and homology toAlthough renal malformations were not noted in the
neural cell adhesion molecule, suggesting adhesive roles,“definitive” report of the syndrome [61], Hardelin et al
and also a “four disulfide core motif” with homology todocumented renal agenesis in association with a stop
antiproteinases. Recent evidence confirms an adhesive
mutation in the KAL-1 gene [62], and Kirk et al subse-
role for neurites in culture [76] and for diverse other cells,
quently established that 37% of 17 patients had a solitary including the renal LLCPK epithelial line. In addition,
kidney as assessed by 99mTechnetium-dimercaptosuccinic KAL-1 is expressed in the developing central nervous
acid scanning to delineate renal parenchyma [63]. This and excretory systems [77]. At 11 weeks of human gesta-
study also documented a male infant with the Potter tion, KAL-1 mRNA localized to the olfactory bulb, sup-
sequence compatible with bilateral renal agenesis, giving porting the hypothesis that anosmin-1 enables migrating
a total incidence of 40% for renal anomalies. On occa- precursors and elongating axons to enter the brain and
sion, other urinary tract anomalies occur, including du- synapse at this site. KAL-1 transcripts were detected in
plex systems, hydronephrosis, and vesicoureteric [64, 65]. the human mesonephros and metanephros at 6 weeks
Autopsy studies of Kallmann’s syndrome kidneys are gestation and in the metanephros at 11 weeks, supporting
rare, although Ishida confirmed renal agenesis in one the contention that the KAL-1 gene product is directly
report [66]. Patients with urinary tract agenesis also lack involved in nephrogenesis. More recently, Hardelin et
the vas deferens, a structure derived from the mesoneph- al reported that anosmin-1 immunolocalized to the epi-
ric duct, which also gives rise to the ureter and collecting thelial interstitial matrix and basement membranes of
ducts. Urinary tract anomalies have also been reported the mesonephric collecting tubules and mesonephric
in two sisters with the autosomal form of the syndrome (Wolffian) duct and to the first generations of metaneph-
[67]; however, this may be a chance association. ric collecting duct branches of the ureteric bud [78].
We studied the seven X-linked Kallmann’s syndrome Collectively, the data are consistent with a role for anos-
patients aged 22 to 35 years who were known to have soli- min-1 in mediating cell adhesion during growth of the
tary kidneys [68]. Two had proteinuria with arterial hyper- ureteric bud lineage, although other nonadhesive roles
tension, and one of these patients developed chronic remain possible. It is possible that failure of growth of
renal failure in the second decade. The five remaining either the ureteric bud or its first branches would lead
patients had normal plasma creatinine concentrations to a failure of metanephric formation and hence renal
without excess microalbuminuria, although four had bor- agenesis. Certainly, other adhesion molecules have been
derline hypertension. In one kindred, an uncle with Kall- considered critical for normal nephrogenesis in murine
mann’s syndrome had chronic renal failure, but the de- models [79–82]. Presently, there are no published data
tails of his nephropathy were unavailable for review. In to establish whether the gene is expressed in the adult
two sets of patients with single kidneys from the same kidney but it is speculated that, if ansomin-1 was also
kindreds, there was a striking temporal discordance for expressed in mature kidney, KAL-1 mutations might
the occurrence of proteinuria and renal impairment. Per- cause progressive renal disease as well as kidney malfor-
mations. In this context, the WT1 transcription factorhaps these patients with solitary kidney and renal impair-
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protein is expressed in mature podocytes and in renal monly encountered by nephrologists and urologists? It
is common clinical experience that most cases of renalmesenchyme: Heterozygous WT1 mutations cause glo-
merulosclerosis in the Denys-Drash [83] and Frasier syn- agenesis and dysplasia appear to be sporadic. However,
in 1974, Cain et al cited 12 reports of familial renal malfor-dromes [84], whereas homozygous null mutations cause
renal agenesis in mice [25]. It is notable that anosmin-1 is mations and described a kindred with two siblings [90]:
the first with bilateral renal agenesis and the second withhighly expressed in the basement membranes of human
mesonephric glomeruli [78], transient structures that are unilateral agenesis and contralateral dysplasia. Others
reported that first-degree relatives of patients with bilat-well differentiated in early gestation. Further studies are
necessary to determine whether the protein also localizes eral urinary tract agenesis had a tenfold higher incidence
of solitary kidney compared with controls [91]. In fact,to postnatal glomeruli.
Numerous questions remain concerning renal disease there is considerable anecdotal evidence that establishes
the possibility of the genetic basis of diverse other uri-in Kallmann’s syndrome. First, why are only some pa-
tients affected by a malformation, even in one kindred? nary tract malformations, which are not associated with
multiorgan syndromes. These include kindreds with renalHere, modifying genes can be invoked, as well described
in mutant mice with renal malformations [27–29]. A par- agenesis [92], renal aplasia and dysplasia [93, 94], multi-
cystic dysplastic kidney [95, 96], oligomeganephronic re-allel situation is established in the additive effects of
PKD1 and TSC2 mutations, which enhance the severity nal hypoplasia [97], renal tubular dysgenesis [98], pelvi-
ureteric junction obstruction [99], and vesicouretericof polycystic kidney disease [85]. With respect to the
hypothesis that interacting mutations may be required reflux [100, 101] and posterior urethral valves [102].
for the generation of urinary tract agenesis, Colquhoun-
Kerr et al reported a family with X-linked Kallmann’s
A URINARY TRACT MALFORMATION LOCUS
syndrome confirmed by mutation analysis, some of whom
ON CHROMOSOME 6?
also had urinary tract agenesis [86]. Conversely, other
An observation made by numerous investigators hasmembers of the kindred had renal agenesis, but did not
been that different types of urinary tract malformationhave classic features of the Kallmann’s syndrome nor
can occur in the same kindred [103–105]. This is compati-did they harbor KAL-1 mutations. Second, why do only
ble with the hypothesis that specific mutations can poten-40% and not 100% of X-linked Kallmann’s syndrome
tially affect the development of the whole urinary tract,patients have an absence of one, rather than both urinary
but that the final phenotype depends on modifying fac-tracts, resulting in unilateral, rather than bilateral renal
tors, either genetic or environmental, which vary fromagenesis? Perhaps, in order to affect nephrogenesis ad-
individual to individual. In support of such a contention,versely, there needs to be a second perturbation in neph-
Devriendt and Fryns proposed that there existed a ge-rogenic precursor cells. This “second hit” could be a
netic locus on short arm of chromosome 6 for multicysticsomatic mutation in another nephrogenesis gene. Cer-
renal dysplasia, pelviureteral junction stenosis, and vesi-tainly, renal somatic mutations do contribute to cysto-
coureteric reflux [106]. Their evidence was twofold.genesis in autosomal dominant polycystic kidney disease
First, Izquierdo et al [99] and Macintosh, Almarhoos,[87] and renal tumor formation [88]. Finally, other fac-
and Heath [107] had, respectively, provided linkage oftors must determine why renal morbidity occurs in pa-
hydronephrosis and vesicoureteric reflux families to HLAtients with a single kidney, based on the temporal dis-
markers on 6p. Second, a fetal termination with bilateralcordance of proteinuria and renal impairment in indi-
multicystic dysplastic kidneys was found to have a t(6:19)viduals from a single kindred. Here again, there are
(p21;q13.1), a translocation that Groenen et al [108, 109]parallel examples from animals experiments such as the
determined to interrupt the CDC5L gene on chromo-Os mouse in which the kidney has significantly fewer
some 6 and the upstream stimulator factor 2 gene onnephrons than normal. However, the subsequent devel-
chromosome 19. Transcripts for both genes were widelyopment of glomerulosclerosis is affected by the genetic
expressed in adult tissues, including kidney, while otherbackground of particular strains [89].
evidence implicates both genes in cell cycle control.
However, CDC5L mutations could not be identified in 10
GENETICS OF NONSYNDROMAL HUMAN fetuses with severe bilateral urinary tract malformations,
URINARY TRACT MALFORMATIONS and there was no linkage of polymorphic markers near
the CDC5L gene in a large family with vesicouretericThe examples of the renal-coloboma and Kallmann’s
syndromes, as well as other congenital syndromes with a reflux (PhD thesis, Genetic studies on renal malforma-
tions, Catholic University of Leuven, Belgium, 1999).genetic basis [19, 20], establish beyond doubt that urinary
tract malformations can be caused by mutations. Is there Hence, while there is some evidence that 6p harbors a
urinary tract malformation locus, the jury is out regard-any evidence that mutations have a pathogenetic role in
the nonsyndromic urinary tract anomalies more com- ing the genes involved.
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ANGIOTENSIN II RECEPTOR 2: A GENE FOR (2) The use of angiotensin-converting enzyme inhibi-
ALL MALFORMATIONS? tors to treat hypertension during pregnancy can cause
neonatal renal failure, which may have a hemodynamicConsiderable evidence from animal experiments sug-
basis or be produced by a lesion that resembles renalgests that angiotensin is important for urinary tract devel-
tubular dysgenesis. This can be associated with a skullopment. For example, mice engineered to lack either
malformation called hypocalvaria [119–121]. Of note,angiotensin II type 1A and 1B (AT1) receptor genes or
a strikingly similar disorder occurs in the absence ofthe angiotensinogen gene fail to develop a normal renal
teratogen exposure [98, 122], and perhaps these individu-medulla and have delayed glomerular maturation [110].
Similar effects can be elicited by pharmacological inhibi- als harbor mutations that affect angiotensin’s action.
tion of angiotensin II activity in rodents during early (3) Human renal dysplasia can rarely be associated
postnatal life [111, 112]. Recently, Miyazaki et al clarified with high plasma renin activity and systemic hyperten-
certain roles for angiotensin in urinary tract development sion [123, 124]. Furthermore, in a preliminary report,
[113]. In mutant mice lacking AT1 alleles, a failure of Yang et al immunolocalized renin to dysplastic mesen-
normal renal pelvis development resulted in urinary sta- chyme (abstract; J Am Soc Nephrol 10:445A, 1999), while
sis and progressive kidney damage, and their ureteral AT1 protein was detected in undifferentiated mesen-
smooth muscle was hypoplastic and lacked peristaltic chyme and epithelia of dysplastic kidneys, and low levels
movements. In wild-type mice, expression of both renal of AT2 mRNA could be detected by reverse transcrip-
angiotensin and the receptor were transiently up-regu- tion-polymerase chain reaction (RT-PCR) of whole or-
lated at the renal outlet at birth, and it was found that gans. However, the link between deregulated renin ex-
angiotensin induced ureteral smooth muscle in organ pression and hypertension is not simple since these
cultures of wild-type mice. patients were normotensive.
Null mutations of the angiotensin II type 2 receptor
gene (AT2), located on the X chromosome, lead to a
spectrum or urinary tract malformations in male mice GENETIC STUDIES IN PRIMARY,
including renal dysplasia, hypoplasia, hydronephrosis, NONSYNDROMIC VESICOURETERIC REFLUX
and vesicoureteric [114]. The biological basis for the
Vesicoureteric reflux describes the passage of urineAT2 phenotype is thought to be delayed apoptosis of
from the bladder into the upper urinary tract. It can bemesenchymal cells in the fetal kidney and lower urinary
secondary to bladder outlet obstruction and can occurtract [114–116]. However, the fact that the malformation
as part of a multiorgan syndrome such as that associatedphenotype was variable in mice with the null mutation,
with PAX2 mutation. Much more commonly, however,together with the fact that other null mutants have no
it is primary and nonsyndromic (MIM 193000) and sys-urinary tract malformation at all [117], again argues that
tematic screening with cystograms that suggest that thethe final phenotype is strongly dependent on modifying
disorder affects 1 to 2% of the Caucasian populationgenes or nongenetic factors.
Several lines of evidence suggest that the renin-angio- [125, 126]. Although there is no experimental evidence
tensin is also important in human urinary tract develop- that reflux in the absence of obstruction is harmful to
ment. the kidney [127], associated renal parenchymal disease,
(1) Nishimura et al reported an association of a poly- or “reflux nephropathy,” causes up to 15% of chronic
morphism of intron 1 of the AT2 gene (the A-1332G renal failure in children and adults. The nephropathy is
transition, which perturbs AT2 mRNA splicing effi- likely to have two main etiologies. First, the passage of
ciency) in U.S. and European patients with multicystic infected urine into the renal parenchyma via compound
dysplastic kidneys and/or pelviureteric obstruction [114]. papillae can lead to acute pyelonephritis in children fol-
The polymorphism occurred in 19 to 42% of normal lowed by scarring. This is especially common in girls.
subjects and 74 to 77% of patients. Subsequently, Ho-
Second, it is increasingly recognized that primary vesi-
henfellner et al reported an association of this polymor-
coureteric reflux can be associated with renal dysplasiaphism with a malformation called obstructive megaure-
and hypoplasia [128, 129]. These patients are usuallyter [118]. Apart from a direct biological effect of this
boys with severe grades of reflux; this population hasgenetic change, an alternative explanation for the associ-
been defined only relatively recently with the advent ofation with urinary tract malformations would be that the
routine fetal ultrasound scanning.AT2 polymorphism may be in linkage dysequilibrium
Genetics may play a role in the pathogenesis of pri-with a separate, causative, mutation of a nearby gene.
mary vescioureteric reflux because there is a 30- to 50-A final explanation for the apparent association is that
fold increased risk of the disorder in immediate relativesthe analyses were confounded by patients and controls
of probands versus the general population [130–132],being drawn from separate populations with different
genetic backgrounds. with the inheritance in many kindreds appearing to be
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of AT2. Hohenfellner et al were unable to find an associa-
tion of the AT2 A-1332G transition in 23 patients pri-
mary with vesicoureteric reflux versus 19 controls [136],
and Choi et al excluded PAX2 mutations in kindreds
with nonsyndromic vesicoureteric reflux [137].
Finally, it is also possible that genetic variation affects
renal inflammation and the generation of interstitial fi-
brosis after acute pyelonephritis. There is evidence of
an association between scar formation in children with
Fig. 3. Familial primary, nonsyndromic vesicoureteric reflux. A fe- vesicoureteric reflux and polymorphisms of the angioten-
male in generation III presented in childhood with urinary infection sin-converting enzyme (ACE) gene. Ozen et al reported
and was found to have vesicoureteric reflux and reflux nephropathy
an association with an insertion/deletion polymorphismaccompanied by chronic renal impairment and hypertension. Subse-
quently, her 12 siblings were screened by cystogram and isotope reno- in intron 16 of this gene [138]: The particular genotype
gram and 6 were found to have vesicoureteric reflux and/or reflux (DD) is associated with increased ACE levels. A similar
nephropathy. The paternal grandmother (generation I) died when a
observation was made by Horikawa et al [139].young adult with hypertension and renal failure. Both parents (genera-
tion II) were well but have not been investigated by cystogram. The
disease inheritance is compatible with a dominant pattern (family tree
extended from Feather et al [100]; personal observation). CONCLUSIONS
Malformations of the urinary tract are common causes
of chronic renal failure in infants and young children,
and there is emerging evidence of how mutations alterdominant with variable penetrance and expression (Fig. 3)
gene expression during development to cause some of[133]. We recently reported the results of the first ge-
these disorders. The most convincing studies come fromnome-wide search of vesicoureteric reflux in seven Euro-
the multiorgan malformation syndromes in which spe-pean families with up to seven affecteds who had an
cific mutations have been defined. However, these syn-apparent dominant inheritance pattern [134]. Patients
dromes are relatively rare, and most urinary tract malfor-were only classified as “affected” if reflux had been diag-
mations appear to occur in isolation. In some of thesenosed by cystogram. Other individuals with only “soft”
individuals, a genetic pathogenesis is strongly suggestedsigns such as urinary tract infection or hypertension
by a positive family history and genetic linkage studies;were classified as “unknown.” We used 387 polymorphic
one common example is primary vesicoureteric reflux.markers spaced at 10 cM through the genome and used
Furthermore, sporadic malformations have been shownboth parametric and nonparametric linkage analyses with
to be associated with polymorphisms of genes expressedthe GENEHUNTER program in order to consider the
during construction of the urinary tract. In the long term,possibilities that the disease might be either mongenic
an understanding of the genetic aspects of human urinaryor polygenic [135]. A locus on the short arm of chromo-
tract malformations will help to unravel the pathogenesissome 1 spanning 20 cM between markers GATA176C01
of these disorders and may facilitate the design of geneticand D1S1653 had a parametric lod score of 3.2 (3.0 is
screening tests with a view to early diagnosis and appro-accepted as significant for evidence of autosomal linkage).
priate genetic counseling.Although the data are suggestive that an important
vesicouretic reflux locus exists on chromosome 1p, spe-
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